Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by Alba1314on Dec 21, 2018 8:03am
74 Views
Post# 29144996

RE:RE:RE:RE:ICO Partner Immune Trading at 1.1 Cent!!!

RE:RE:RE:RE:ICO Partner Immune Trading at 1.1 Cent!!!That's a pretty good point. My fear has been that will a PP will occur but for a ridiculous amount of new shares issued, watering down the current the float. Good chance this may happen. Best scenario, though doubtful, is an investor trading cash for generous future royaly payments.

But I think regardless is nearer the mark
<< Previous
Bullboard Posts
Next >>